Fibromyalgia drug tested in elderly: does age matter?
NCT ID NCT07413367
First seen Jun 27, 2026 · Last updated Jun 27, 2026
Summary
This study looks at how the fibromyalgia medication TNX-102 SL (taken under the tongue) is processed in the body of older adults (65+) compared to younger adults (18-45). About 50 healthy participants will receive a single dose, and researchers will measure drug levels and safety. The goal is to understand if age affects how the drug works, which can help guide proper dosing for older patients.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for OPEN LABEL are added.
By submitting, you agree to our Terms of use
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Locations
-
Syneos Health Clinique, Inc.
Québec, Quebec, G1P 0A2, Canada
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- New vaginal capsule aims to tackle stubborn bacterial vaginosis
- New drug takes aim at Hard-to-Treat sarcoma
- Supercharged immune cells take on deadly brain tumors
- Pfizer tests new pill form in healthy volunteers to see how food and acid reducers affect drug levels
- New hope for Tough-to-Treat colon cancer? early trial launches
- New drug combo targets tough cancers in early trial